Jasper Therapeutics Inc (JSPR)
22.98
+0.14
(+0.59%)
USD |
NASDAQ |
May 17, 16:00
22.98
0.00 (0.00%)
After-Hours: 20:00
Jasper Therapeutics Enterprise Value: 228.80M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 228.80M |
| May 16, 2024 | 226.16M |
| May 15, 2024 | 207.37M |
| May 14, 2024 | 197.12M |
| May 13, 2024 | 194.70M |
| May 10, 2024 | 203.30M |
| May 09, 2024 | 204.66M |
| May 08, 2024 | 201.19M |
| May 07, 2024 | 225.02M |
| May 06, 2024 | 220.05M |
| May 03, 2024 | 251.42M |
| May 02, 2024 | 243.28M |
| May 01, 2024 | 243.43M |
| April 30, 2024 | 241.62M |
| April 29, 2024 | 212.20M |
| April 26, 2024 | 189.27M |
| April 25, 2024 | 201.04M |
| April 24, 2024 | 213.86M |
| April 23, 2024 | 215.07M |
| April 22, 2024 | 221.25M |
| April 19, 2024 | 207.22M |
| April 18, 2024 | 231.66M |
| April 17, 2024 | 240.86M |
| April 16, 2024 | 246.14M |
| April 15, 2024 | 278.28M |
| Date | Value |
|---|---|
| April 12, 2024 | 299.70M |
| April 11, 2024 | 320.21M |
| April 10, 2024 | 303.02M |
| April 09, 2024 | 327.76M |
| April 08, 2024 | 334.09M |
| April 05, 2024 | 326.55M |
| April 04, 2024 | 296.98M |
| April 03, 2024 | 290.34M |
| April 02, 2024 | 276.77M |
| April 01, 2024 | 308.45M |
| March 28, 2024 | 355.39M |
| March 27, 2024 | 347.25M |
| March 26, 2024 | 333.25M |
| March 25, 2024 | 330.38M |
| March 22, 2024 | 353.43M |
| March 21, 2024 | 360.06M |
| March 20, 2024 | 326.92M |
| March 19, 2024 | 308.39M |
| March 18, 2024 | 287.60M |
| March 15, 2024 | 290.92M |
| March 14, 2024 | 279.92M |
| March 13, 2024 | 316.67M |
| March 12, 2024 | 304.77M |
| March 11, 2024 | 312.61M |
| March 08, 2024 | 328.12M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-56.62M
Minimum
Dec 13 2023
520.03M
Maximum
Oct 15 2021
78.12M
Average
38.20M
Median
Jul 03 2023
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 16.77M |
| Theriva Biologics Inc | -8.901M |
| Oragenics Inc | 8.862M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.73M |
| Total Expenses (Quarterly) | 15.07M |
| EPS Diluted (Quarterly) | -1.03 |
| Earnings Yield | -24.39% |